» Articles » PMID: 18249037

Increase in B-cell-activation Factor (BAFF) and IFN-gamma Productions by Tonsillar Mononuclear Cells Stimulated with Deoxycytidyl-deoxyguanosine Oligodeoxynucleotides (CpG-ODN) in Patients with IgA Nephropathy

Overview
Journal Clin Immunol
Date 2008 Feb 6
PMID 18249037
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

IgA nephropathy (IgAN), the most common form of primary glomerulonephritis, is recognized as a tonsil-related diseases since it often gets worse after and/or during acute tonsillitis and the disease progression is often prevented by tonsillectomy. Although several reports showed an increase in IgA production of tonsillar mononuclear cells (TMCs), its mechanism has not yet been fully clarified. Recently, B-cell-activation factor (BAFF), which stimulates B-cell proliferation and immunoglobulin production, was identified. Unmethylated deoxycytidyl-deoxyguanosine oligodeoxynucleotide (CpG-ODN), which is able to mimic the immunostimulatory activity of microbial DNA, is known to be involved in the production of immunoglobulins and some cytokines. In this study, we focused on roles of BAFF and IFN-gamma in IgA production of TMCs stimulated with CpG-ODN in IgAN patients. Two-color flow cytometric analysis revealed that the intercellular expression of IFN-gamma on the T-cells freshly isolated from tonsils was significantly higher in IgAN patients than in non-IgAN patients (p=0.032). The spontaneous productions of IgA and IFN-gamma of TMCs were significantly higher in IgAN patients than in non-IgAN patients (p=0.023 and p=0.02). Under stimulation with CpG-ODN, the productions of IgA, BAFF and IFN-gamma of TMCs were significantly higher in IgAN patients than in non-IgAN patients (p=0.013, p=0.005 and p=0.039). The IgA production of TMCs stimulated by CpG-ODN was inhibited by the treatment with anti-BAFF antibody and/or anti-IFN-gamma antibody. Under stimulation with IFN-gamma, the BAFF expression on the CD1c cells and the BAFF production of TMCs were significantly higher in IgAN patients than in non-IgAN patients (p=0.004 and p=0.042). These data suggest that hyper-immune response to microbial DNA may be present in IgAN patients and may lead to hyperproduction of BAFF up-regulated by IFN-gamma, resulting in hyperproduction of IgA in IgAN patients.

Citing Articles

Lessons from IgA Nephropathy Models.

Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M Int J Mol Sci. 2024; 25(21).

PMID: 39519036 PMC: 11546737. DOI: 10.3390/ijms252111484.


New Insights and Future Perspectives of APRIL in IgA Nephropathy.

Muto M, Suzuki H, Suzuki Y Int J Mol Sci. 2024; 25(19).

PMID: 39408691 PMC: 11476402. DOI: 10.3390/ijms251910340.


Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy.

Makita Y, Reich H J Clin Med. 2024; 13(17).

PMID: 39274468 PMC: 11396043. DOI: 10.3390/jcm13175255.


Accelerated involution of germinal center in palatine tonsils in IgA nephropathy.

Ueda H, Joh K, Ueda Y, Marumoto H, Okabe M, Isaka N PLoS One. 2024; 19(5):e0301853.

PMID: 38709804 PMC: 11073668. DOI: 10.1371/journal.pone.0301853.


The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.

Cheung C, Barratt J, Liew A, Zhang H, Tesar V, Lafayette R Front Nephrol. 2024; 3:1346769.

PMID: 38362118 PMC: 10867227. DOI: 10.3389/fneph.2023.1346769.